CORRECTION article

Front. Immunol., 15 July 2025

Sec. Primary Immunodeficiencies

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1659197

Correction: EBV-positive diffuse large B cell lymphoma secondary to activated phosphoinositide 3 kinase δ syndrome type 1 (APDS1): a case report and literature review

  • 1. Department of Hematology, The Second Clinical Medical College of Jinan University, Shenzhen, China

  • 2. Department of Pathology, Shenzhen People’s Hospital (The Second Clinical Medical College of Jinan University; The First Affiliated Hospital of Southern University of Science and Technology), Shenzhen, China

  • 3. Department of Hematology, Shenzhen People’s Hospital (The Second Clinical Medical College of Jinan University; The First Affiliated Hospital of Southern University of Science and Technology), Shenzhen, China

Wrong affiliation, but not replacing with present address

Author “Min Zuo” was erroneously assigned to affiliation “Department of Pathology, The Second Clinical Medical College of Jinan University, Shenzhen, China”.

The correct affiliation is “Department of Pathology, Shenzhen People’s Hospital (The Second Clinical Medical College of Jinan University; The First Affiliated Hospital of Southern University of Science and Technology), Shenzhen, China”.

Authors “Ji-Hao Zhou and Chun Feng” were erroneously assigned to affiliation “Department of Hematology, The Second Clinical Medical College of Jinan University, Shenzhen, China”.

The correct affiliation is “Department of Hematology, Shenzhen People’s Hospital (The Second Clinical Medical College of Jinan University; The First Affiliated Hospital of Southern University of Science and Technology), Shenzhen, China”.

The original version of this article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

activated phosphoinositide 3-kinase δ syndrome, Epstein-Barr virus, diffuse large B-cell lymphoma, Epstein-Barr virus-positive diffuse large B-cell lymphoma (EBV+ DLBCL), inborn error of immunity

Citation

Xiang Q, Zuo M, Zhou J-H and Feng C (2025) Correction: EBV-positive diffuse large B cell lymphoma secondary to activated phosphoinositide 3 kinase δ syndrome type 1 (APDS1): a case report and literature review. Front. Immunol. 16:1659197. doi: 10.3389/fimmu.2025.1659197

Received

03 July 2025

Accepted

04 July 2025

Published

15 July 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

16 - 2025

Updates

Copyright

*Correspondence: Ji-Hao Zhou, ; Chun Feng,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics